- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Viemed Healthcare Inc (VMD)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: VMD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $13
1 Year Target Price $13
| 3 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -16.31% | Avg. Invested days 32 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 280.81M USD | Price to earnings Ratio 21.29 | 1Y Target Price 13 |
Price to earnings Ratio 21.29 | 1Y Target Price 13 | ||
Volume (30-day avg) 3 | Beta 1.25 | 52 Weeks Range 5.93 - 8.62 | Updated Date 01/10/2026 |
52 Weeks Range 5.93 - 8.62 | Updated Date 01/10/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.34 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.34% | Operating Margin (TTM) 9.69% |
Management Effectiveness
Return on Assets (TTM) 6.49% | Return on Equity (TTM) 10.66% |
Valuation
Trailing PE 21.29 | Forward PE 15.2 | Enterprise Value 288824646 | Price to Sales(TTM) 1.1 |
Enterprise Value 288824646 | Price to Sales(TTM) 1.1 | ||
Enterprise Value to Revenue 1.13 | Enterprise Value to EBITDA 5.96 | Shares Outstanding 38017907 | Shares Floating 30219674 |
Shares Outstanding 38017907 | Shares Floating 30219674 | ||
Percent Insiders 13.52 | Percent Institutions 66.91 |
Upturn AI SWOT
Viemed Healthcare Inc

Company Overview
History and Background
Viemed Healthcare Inc. was founded in 2000. It has evolved from a local home medical equipment provider to a diversified healthcare services company focused on post-acute care. Key milestones include strategic acquisitions and expansion into new service lines.
Core Business Areas
- Respiratory Home Medical Equipment: Viemed provides a comprehensive suite of respiratory-related home medical equipment and services, including ventilators, CPAP machines, oxygen therapy, and associated supplies and support. This segment focuses on patients with chronic respiratory conditions.
- Home Infusion Therapy: This segment offers specialized infusion services in the patient's home, including intravenous medications, hydration, and nutritional support. It caters to patients requiring complex therapies that can be safely administered outside of a hospital setting.
- Clinical Services: Viemed also provides integrated clinical services, such as patient education, care coordination, and monitoring, to ensure optimal patient outcomes and adherence to treatment plans.
Leadership and Structure
Viemed Healthcare Inc. is led by a management team with extensive experience in the healthcare industry. The organizational structure is designed to support its diverse service lines and geographic reach, with a focus on operational efficiency and patient care.
Top Products and Market Share
Key Offerings
- Ventilator Therapy and Support: Viemed is a leading provider of home-based ventilator therapy, offering advanced mechanical ventilators and comprehensive respiratory support services for patients with conditions like COPD, ALS, and neuromuscular disorders. Competitors include Apria Healthcare, LHC Group, and smaller regional providers. Market share data is not publicly disclosed for this specific product line, but Viemed holds a significant position in the post-acute respiratory care market.
- CPAP/BiPAP Machines and Supplies: The company offers a range of Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) machines for the treatment of sleep apnea and other sleep-disordered breathing. This includes masks, tubing, and cleaning supplies. Competitors are numerous and include large national DME providers and specialized sleep therapy companies.
- Home Infusion Services: Viemed delivers a variety of infusion therapies, including antibiotics, pain management, and total parenteral nutrition (TPN), directly to patients' homes. This service competes with other home infusion companies and hospital-based outpatient infusion centers.
Market Dynamics
Industry Overview
The home healthcare industry, particularly post-acute care, is experiencing significant growth driven by an aging population, increasing prevalence of chronic diseases, and a shift towards cost-effective care delivered in the home setting. Regulatory changes and reimbursement policies play a crucial role in shaping the market.
Positioning
Viemed is positioned as a comprehensive provider of post-acute care services, with a strong emphasis on respiratory and infusion therapies. Its integrated model, combining equipment, clinical support, and care coordination, offers a competitive advantage by aiming for improved patient outcomes and reduced hospital readmissions.
Total Addressable Market (TAM)
The TAM for home healthcare services, including durable medical equipment (DME) and home infusion, is substantial and growing. Projections estimate the global home healthcare market to reach hundreds of billions of dollars in the coming years. Viemed operates within specific segments of this market, focusing on areas where it has developed specialized expertise and strong referral networks. Its market position is influenced by its ability to secure contracts, navigate reimbursement complexities, and provide high-quality patient care.
Upturn SWOT Analysis
Strengths
- Strong focus on specialized post-acute care niches (respiratory, infusion).
- Integrated service model combining equipment, clinical support, and care coordination.
- Established relationships with referral sources (hospitals, physicians).
- Experienced management team.
- Potential for geographic expansion.
Weaknesses
- Dependence on reimbursement from government and private payers.
- Competition from larger, more established healthcare providers.
- Operational complexities associated with managing diverse service lines.
- Potential for integration challenges with acquired entities.
Opportunities
- Increasing demand for home-based care due to an aging population.
- Expansion into new geographic markets.
- Development of new service lines or technologies to enhance patient care.
- Strategic acquisitions to broaden service offerings and market reach.
- Growing focus on value-based care models.
Threats
- Changes in government reimbursement policies (e.g., Medicare, Medicaid).
- Increased competition and price pressures.
- Regulatory changes impacting healthcare providers.
- Economic downturns affecting healthcare spending.
- Technological disruptions in healthcare delivery.
Competitors and Market Share
Key Competitors
- Apria Healthcare (Private)
- LHC Group (LHCG)
- AdaptHealth Corp. (AHCO)
- Curo Health Services (Private)
Competitive Landscape
Viemed's advantages lie in its specialized focus and integrated service model. However, it faces strong competition from larger, national providers with greater scale and broader service portfolios. Its ability to secure favorable reimbursement contracts and maintain high-quality patient care is crucial for maintaining and growing its market share.
Growth Trajectory and Initiatives
Historical Growth: Viemed has demonstrated a pattern of growth through a combination of organic expansion and strategic acquisitions within the fragmented home healthcare market. Its historical growth trajectory has likely been influenced by its ability to integrate acquired businesses effectively and expand its service offerings.
Future Projections: Future growth projections for Viemed are likely contingent on its ability to capitalize on the increasing demand for home-based post-acute care, expand its geographic footprint, and potentially enter new service areas. Analyst estimates would provide insights into expected revenue and earnings growth.
Recent Initiatives: Recent initiatives may include the integration of newly acquired companies, expansion into new service lines, investments in technology to improve operational efficiency and patient care, and efforts to strengthen relationships with healthcare providers and referral sources.
Summary
Viemed Healthcare Inc. is a growing player in the post-acute care sector, with a strong focus on respiratory and home infusion services. Its integrated model and strategic acquisitions have driven historical growth. However, the company faces significant competition and is reliant on evolving reimbursement policies. Continued success will depend on its ability to effectively integrate acquisitions, expand its service offerings, and navigate a complex regulatory environment.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Financial news outlets
Disclaimers:
This analysis is based on publicly available information and should not be considered investment advice. Financial data and market share estimates are subject to change and may not be exhaustive.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Viemed Healthcare Inc
Exchange NASDAQ | Headquaters Lafayette, LA, United States | ||
IPO Launch date 2017-12-22 | CEO & Director Mr. Casey Hoyt | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1380 | Website https://www.viemed.com |
Full time employees 1380 | Website https://www.viemed.com | ||
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

